uniQure Investor Relations Material
Latest events
Q2 2025
uniQure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from uniQure N.V.
Access all reports
uniQure N.V. is a biotechnology company that develops gene therapies for the treatment of genetic diseases. The company uses viral vector platforms to deliver therapeutic genes to targeted tissues. It focuses on research, clinical development, and manufacturing of gene-based treatments. The company is headquartered in Amsterdam, Netherlands, and its shares are listed on the NASDAQ.
Key slides for uniQure N.V.
Corporate Presentation
uniQure N.V.
Corporate Presentation
uniQure N.V.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
QURE
Country
🇺🇸 United States